Assistant Professor, Dermatology, University of Texas Southwestern Medical Center, Southwestern Medical School
Dermatology
Dr. Heidi Jacobe, MD
|
|
Give Review
Heidi Jacobe works in the field of Dermatology. She researched medicine at University of Texas Southwestern Medical School. She received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAD)". Heidi Jacobe is also a published physician. She has 37 publication published. The most recent publication is: Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. She accepts Medicare.
Publications
- Attitudes and trends in the treatment of morphea: A national survey.
- Health-Related Quality of Life in Morphea.
- Major histocompatibility complex (MHC) class I and II alleles which confer susceptibility or protection in the Morphea in Adults and Children (MAC) cohort.
- Morphea in adults and children cohort VI: A cross-sectional comparison of outcomes between adults with pediatric-onset and adult-onset morphea.
- The role of Skin trauma in the distribution of morphea lesions: A cross-sectional survey of the Morphea in Adults and Children cohort IV.
- Correlates of self-reported quality of life in adults and children with morphea.
- Recurrence of morphea after successful ultraviolet A1 phototherapy: A cohort study.
- Clinical Features of Patients with Morphea and the Pansclerotic Subtype: A Cross-sectional Study from the Morphea in Adults and Children Cohort.
- Morphea in Adults and Children Cohort III: Nested Case-Control Study-The Clinical Significance of Autoantibodies in Morphea.
- Recent developments in diagnosis and assessment of morphea.
- Morphea and other localized forms of scleroderma.
- Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment.
- Do automated text messages increase adherence to acne therapy? Results of a randomized, controlled trial.
- Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in Skin.
- Dermatopathology of connective tissue diseases.
- Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque Psoriasis: a meta-analysis of randomized controlled trials.
- Photoimmunology--illuminating the immune system through photobiology.
- UVA1 phototherapy is effective in darker Skin: a review of 101 patients of Fitzpatrick Skin types I-V.
- Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases.
- Addictive-like behaviours to ultraviolet light among frequent indoor tanners.
- UVA1 phototherapy: a review of mechanism and therapeutic application.
- Argyria secondary to ingestion of homemade silver solution.
- "Blind man dermatology" revisited.
- Understanding clinical trial outcomes: design, analysis, and interpretation.
- Ultrasound as an outcome measure to assess disease activity in disorders of Skin thickening: an example of the use of radiologic techniques to assess Skin disease.
- An evaluation of long-term outcomes in adults with pediatric-onset morphea.
- A systematic review of morphea treatments and therapeutic algorithm.
- 14-MHz ultrasonography as an outcome measure in morphea (localized scleroderma).
- Phototherapy in the age of biologics.
- Phototherapy in the management of atopic Dermatitis: a systematic review.
- UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States.
- Sertraline as a first-line treatment for cholestatic pruritus.
- Thalidomide as a potential treatment for scleromyxedema.
- Reversible alopecia associated with glatiramer acetate.
- UV-A1 therapy for nephrogenic systemic fibrosis.
- The role of narrowband UV-B plus alefacept combination therapy in the treatment of Psoriasis.
Conditions Treated
- Actinic Keratosis
- Basal Cell Carcinoma
- Benign Skin Lesion
- Dermatitis
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAD)
Education
-
University of Texas Southwestern Medical School -
Baylor College of Medicine
Hospital
-
University of Texas Southwestern Medical Center -
Children's Health System of Texas -
Parkland Health & Hospital System -
Veterans Affairs North Texas Health Care System
Drug Facts
| NPI NUMBER | 1225097538 | |
| NPPES Provider LastName | JACOBE | |
| NPPES Provider FirstName | HEIDI | |
| NPPES Provider ZIPCode | 753909069 | |
| NPPES Provider State | TX | |
| Specialty Description | Dermatology | |
| Total Claim Count | 181.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1225097538 |
| Last Name Of The Provider | JACOBE |
| First Name Of The Provider | HEIDI |
| View All |
Similar Doctors
|
Dr. Mary E. Hurley, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Melissa I. Costner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah B. Weitzul, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Erica L. Muller, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William D. Posten, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Forrest C. Brown, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Miriam S. Singer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Saira B. Momin, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel Zaghi, MD |
|
|
Dr. Maria J. Quintanilla-Dieck, MD |
|
|
Dr. Donald A. Glass II, MD |
|
|
Dr. Patrick H. McDonough, MD |
|
|
Dr. Lynne J. Roberts, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth T. Dolan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin R. Kassir, MD
This Doctor is OpenDoctor Recommended.
|